Papers in BMJ Neurology Open
Page 7 · newest first
- Cytotoxic lesions of the corpus callosum (CLOCCs) with a flow gap in straight sinus on magnetic resonance venographyBMJ Neurology Open · 2024
- Detecting signatures of consciousness in acute brain injury after stimulation with apomorphine and methylphenidate: protocol for a placebo-controlled, randomized, cross-over studyBMJ Neurology Open · 2024
- ICAM-1 and CRP as biomarkers of 3-month outcome in acute ischaemic strokeBMJ Neurology Open · 2023
- Weight management communications in idiopathic intracranial hypertension: challenges and recommendations from the patients’ perspectiveBMJ Neurology Open · 2023
- Efficacy of exercises in early-stage Parkinson’s disease (PARK-EASE trial): single-blind, randomised, controlled trialBMJ Neurology Open · 2023
- Assessment of ChatGPT’s performance on neurology written board examination questionsBMJ Neurology Open · 2023
- Improving cognition in people with multiple sclerosis: study protocol for a multiarm, randomised, blinded trial of multidomain cognitive rehabilitation using a video-serious game (E-SEP cognition)BMJ Neurology Open · 2023
- Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson’s disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocolBMJ Neurology Open · 2023
- Cerebral venous sinus thrombosis secondary to acute cytomegalovirus infectionBMJ Neurology Open · 2023
- STAREE-Mind Imaging Study: a randomised placebo-controlled trial of atorvastatin for prevention of cerebrovascular decline and neurodegeneration in older individualsBMJ Neurology Open · 2023
- Evaluation of the efficacy and safety of MRI-guided focused ultrasound (MRgFUS) for focal hand dystonia: study protocol for an open-label non-randomised clinical trialBMJ Neurology Open · 2023
- Physical exercise for treating non-motor symptoms assessed by general Parkinson’s disease scales: systematic review and meta-analysis of clinical trialsBMJ Neurology Open · 2023
- Myths and facts about functional neurological disorders: a cross-sectional study of knowledge and awareness among medical students and healthcare professionals in IraqBMJ Neurology Open · 2023
- Leukoaraiosis and stroke severity scores in post-rtPA intracerebral haemorrhageBMJ Neurology Open · 2023
- Cost-effectiveness of ticagrelor plus aspirin versus aspirin in acute ischaemic stroke or transient ischaemic attack: an economic evaluation of the THALES trialBMJ Neurology Open · 2023
- Out-of-hospital multimodal seizure detection: a pilot studyBMJ Neurology Open · 2023
- Anatomical distribution and clinical significance of middle cerebral artery M2 segment vessel occlusions and its cortical branches in acute ischaemic stroke patientsBMJ Neurology Open · 2023
- Blood pressure medication and acute kidney injury after intracerebral haemorrhage: an analysis of the ATACH-II trialBMJ Neurology Open · 2023
- Evaluating the limits of AI in medical specialisation: ChatGPT’s performance on the UK Neurology Specialty Certificate ExaminationBMJ Neurology Open · 2023
- Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): effects on outcomes at day 365 in a randomised, sham-controlled, blinded, phase III, superiority ambulance-based trialBMJ Neurology Open · 2023
- Effects of blood pressure and tranexamic acid in spontaneous intracerebral haemorrhage: a secondary analysis of a large randomised controlled trialBMJ Neurology Open · 2023
- Muscle spindles as pain receptorsBMJ Neurology Open · 2023
- Opsoclonus myoclonus ataxia syndrome, ovarian teratoma and anti-NMDAR antibody: an ‘unresolved’ mysteryBMJ Neurology Open · 2023
- Retinal vascular density in CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy)BMJ Neurology Open · 2023
- Assessing and managing medication overuse headache in Australian clinical practiceBMJ Neurology Open · 2023
- Modelling accessibility of adult neurology care in Australia, 2020–2034BMJ Neurology Open · 2023
- Postural stability in blepharospasm: the effects of dual-tasking and botulinum toxin therapyBMJ Neurology Open · 2023
- Asymptomatic cerebral small vessel disease in adults with low cardiovascular riskBMJ Neurology Open · 2023
- Neurofilament light oligomers in neurodegenerative diseases: quantification by homogeneous immunoassay in cerebrospinal fluidBMJ Neurology Open · 2023
- Association between socioeconomic status and Parkinson’s disease: findings from a large incident case–control studyBMJ Neurology Open · 2023
- Door-in-door-out times for patients with large vessel occlusion ischaemic stroke being transferred for endovascular thrombectomy: a Victorian state-wide studyBMJ Neurology Open · 2023
- Impact of cognitive impairment on clinical outcomes in elderly patients with atrial fibrillation: ANAFIE RegistryBMJ Neurology Open · 2023
- Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS)BMJ Neurology Open · 2023
- Efficacy of 48 hours dose of phenytoin in prevention of early post-traumatic seizureBMJ Neurology Open · 2023
- Differential age-associated brain atrophy and white matter changes among homeless and precariously housed individuals compared with the general populationBMJ Neurology Open · 2023
- Long-term evaluation parameters in GNE myopathy: a 5-year observational follow-up natural history studyBMJ Neurology Open · 2022
- Deciphering changes in the incidence of the Guillain-Barré syndrome during the COVID-19 pandemic: a nationwide time-series correlation studyBMJ Neurology Open · 2022
- Changing faces of mitochondrial disease: autosomal recessive POLG disease mimicking myasthenia gravis and progressive supranuclear palsyBMJ Neurology Open · 2022
- New-onset refractory status epilepticus (NORSE) in paediatric patients: causes, characteristics and outcomesBMJ Neurology Open · 2022
- Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL StudyBMJ Neurology Open · 2022
- Imaging of extrapontine myelinolysis preceding central pontine myelinolysis in a case of ornithine transcarbamylase deficiency with hyperammonaemia and hypokalaemiaBMJ Neurology Open · 2022
- Cortisol, cognition and Alzheimer’s disease biomarkers among memory clinic patientsBMJ Neurology Open · 2022
- Nationwide survey of Lambert-Eaton myasthenic syndrome in JapanBMJ Neurology Open · 2022
- Efficacy of botulinum toxin type a in the targeted treatment of sleep bruxism: a double-blind, randomised, placebo-controlled, cross-over studyBMJ Neurology Open · 2022
- Cerebrospinal fluid sampling for research of Alzheimer’s disease and other neurodegenerative diseases when lumbar punctures are performed by anaesthetistsBMJ Neurology Open · 2022
- Dementia clinical trials over the past decade: are women fairly represented?BMJ Neurology Open · 2022
- Circle of Willis variation and outcome after intra-arterial treatmentBMJ Neurology Open · 2022
- Survey of healthcare professionals’ knowledge, attitudes and practices regarding spontaneous intracranial hypotensionBMJ Neurology Open · 2022
- Practical utility of the ACT-FAST triage algorithm from a primary stroke centre perspectiveBMJ Neurology Open · 2022
- Group therapeutic singing improves clinical motor scores in persons with Parkinson’s diseaseBMJ Neurology Open · 2022